V
Vina San Pedro Tarapaca SA
SGO:VSPT
Vina San Pedro Tarapaca SA
SGO:VSPT
Price:
4.001
CLP
-2.41%
Market Closed
Market Cap:
159.9B
CLP
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
VSPT Alert
Vina San Pedro Tarapaca SA
4.001
-0.099 (-2.41%)
| 52 Week Range |
3.8
5.528
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CLP.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Vina San Pedro Tarapaca SA
Balance Sheet
Balance Sheet Decomposition
Vina San Pedro Tarapaca SA
Vina San Pedro Tarapaca SA
| Current Assets | 210.8B |
| Cash & Short-Term Investments | 16.2B |
| Receivables | 70.1B |
| Other Current Assets | 124.5B |
| Non-Current Assets | 241.1B |
| PP&E | 187.7B |
| Intangibles | 50.9B |
| Other Non-Current Assets | 2.4B |
| Current Liabilities | 132B |
| Accounts Payable | 44.9B |
| Accrued Liabilities | 5.2B |
| Other Current Liabilities | 81.9B |
| Non-Current Liabilities | 31.7B |
| Long-Term Debt | 4.5B |
| Other Non-Current Liabilities | 27.2B |
Balance Sheet
Vina San Pedro Tarapaca SA
Vina San Pedro Tarapaca SA
Currency: CLP
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3 238
|
22 290
|
14 035
|
3 880
|
4 360
|
20 151
|
14 097
|
30 289
|
4 501
|
5 996
|
|
| Cash |
3 238
|
2 569
|
4 682
|
3 880
|
4 360
|
20 151
|
14 097
|
6 215
|
4 501
|
5 878
|
|
| Cash Equivalents |
0
|
19 721
|
9 353
|
0
|
0
|
0
|
0
|
24 074
|
0
|
118
|
|
| Short-Term Investments |
16 311
|
2 869
|
10 442
|
10 105
|
10 465
|
3 401
|
50 001
|
11 504
|
1 300
|
3 252
|
|
| Total Receivables |
47 763
|
51 952
|
49 568
|
51 051
|
60 597
|
59 461
|
58 991
|
73 538
|
84 428
|
74 396
|
|
| Accounts Receivables |
38 238
|
42 962
|
42 716
|
40 015
|
51 155
|
51 451
|
48 929
|
59 217
|
64 117
|
60 843
|
|
| Other Receivables |
9 525
|
8 990
|
6 852
|
11 036
|
9 443
|
8 010
|
10 062
|
14 321
|
20 310
|
13 553
|
|
| Inventory |
59 455
|
60 992
|
68 652
|
72 855
|
76 641
|
76 560
|
83 023
|
98 609
|
119 109
|
121 226
|
|
| Other Current Assets |
2 683
|
4 841
|
3 169
|
3 224
|
4 055
|
1 577
|
2 613
|
4 633
|
2 678
|
2 233
|
|
| Total Current Assets |
131 405
|
142 945
|
145 866
|
141 115
|
156 118
|
161 150
|
208 725
|
218 573
|
212 017
|
207 103
|
|
| PP&E Net |
104 928
|
103 961
|
110 966
|
114 412
|
126 890
|
159 452
|
163 247
|
170 122
|
176 039
|
171 462
|
|
| PP&E Gross |
104 928
|
103 961
|
110 966
|
114 412
|
126 890
|
159 452
|
163 247
|
170 122
|
176 039
|
171 462
|
|
| Accumulated Depreciation |
83 569
|
85 870
|
84 316
|
88 426
|
91 440
|
98 755
|
104 545
|
106 958
|
116 620
|
118 346
|
|
| Intangible Assets |
20 938
|
20 879
|
20 846
|
20 960
|
21 749
|
21 767
|
21 700
|
21 629
|
21 608
|
21 599
|
|
| Goodwill |
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
|
| Note Receivable |
0
|
0
|
0
|
3
|
440
|
493
|
544
|
929
|
1 103
|
683
|
|
| Long-Term Investments |
0
|
80
|
204
|
0
|
0
|
99
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
10 969
|
11 565
|
10 226
|
9 950
|
7 905
|
9 073
|
2 518
|
2 413
|
3 741
|
3 738
|
|
| Other Assets |
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
28 858
|
|
| Total Assets |
297 145
N/A
|
308 288
+4%
|
316 965
+3%
|
315 299
-1%
|
341 959
+8%
|
380 892
+11%
|
425 592
+12%
|
442 524
+4%
|
443 365
+0%
|
433 444
-2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
27 146
|
30 120
|
32 539
|
30 475
|
30 461
|
29 626
|
39 119
|
52 644
|
45 809
|
41 363
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
4 115
|
5 284
|
4 822
|
4 335
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
13 465
|
13 435
|
11 898
|
13 629
|
30 183
|
31 114
|
31 498
|
16 246
|
4 758
|
17 811
|
|
| Other Current Liabilities |
23 917
|
26 544
|
25 914
|
19 770
|
20 234
|
29 463
|
24 536
|
23 257
|
28 869
|
20 183
|
|
| Total Current Liabilities |
64 528
|
70 099
|
70 351
|
63 873
|
80 878
|
90 204
|
99 267
|
97 431
|
84 258
|
83 693
|
|
| Long-Term Debt |
18 145
|
15 338
|
15 283
|
10 192
|
8 061
|
24 371
|
59 281
|
51 267
|
55 289
|
57 169
|
|
| Deferred Income Tax |
15 689
|
16 472
|
17 490
|
19 526
|
21 585
|
22 617
|
14 220
|
16 486
|
17 796
|
16 168
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
802
|
871
|
1 023
|
1 503
|
1 904
|
2 613
|
3 004
|
7 039
|
3 965
|
4 283
|
|
| Total Liabilities |
99 166
N/A
|
102 780
+4%
|
104 147
+1%
|
95 094
-9%
|
112 428
+18%
|
139 806
+24%
|
175 773
+26%
|
172 224
-2%
|
161 308
-6%
|
161 313
+0%
|
|
| Equity | |||||||||||
| Common Stock |
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
122 344
|
|
| Retained Earnings |
80 974
|
90 095
|
98 901
|
107 759
|
115 161
|
126 270
|
137 495
|
148 699
|
156 951
|
164 080
|
|
| Additional Paid In Capital |
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
1 464
|
|
| Other Equity |
6 804
|
8 395
|
9 891
|
11 362
|
9 438
|
8 992
|
11 484
|
2 207
|
1 298
|
15 758
|
|
| Total Equity |
197 979
N/A
|
205 508
+4%
|
212 818
+4%
|
220 205
+3%
|
229 531
+4%
|
241 087
+5%
|
249 819
+4%
|
270 300
+8%
|
282 057
+4%
|
272 131
-4%
|
|
| Total Liabilities & Equity |
297 145
N/A
|
308 288
+4%
|
316 965
+3%
|
315 299
-1%
|
341 959
+8%
|
380 892
+11%
|
425 592
+12%
|
442 524
+4%
|
443 365
+0%
|
433 444
-2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
39 970
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
